EUPRAXIA PHARMACEUTICALS INC (EPRX.CA) Stock Analyst Ratings
Canada - Toronto Stock Exchange - TSX:EPRX - CA29842P1053 - Common Stock
8.48 CAD
-0.15 (-1.74%)
ChartMill assigns a Buy % Consensus number of 84% to EPRX.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.36. This target is 45.7% above the current price.
EPRX.CA was analyzed by 10 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EPRX.CA.
In the previous month the buy percentage consensus was at a similar level.
EPRX.CA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-08 | Canaccord Capital | Downgrade | Buy |
| 2022-11-01 | Raymond James Capital | Upgrade | Outperform |
| 2022-06-09 | Raymond James Capital | Initiate | Outperform |
| 2022-04-21 | Canaccord Capital | Downgrade | Buy |
| 2022-04-01 | Raymond James Capital | Initiate | Outperform |
| 2021-11-12 | RaymondJamesFinancial | Downgrade | Outperform |
| 2021-08-18 | Canaccord Genuity | Downgrade | Buy |
| 2021-08-17 | Raymond James Financial | Initiate | Outperform |
EUPRAXIA PHARMACEUTICALS INC / EPRX.CA FAQ
Can you provide the average price target for EUPRAXIA PHARMACEUTICALS INC stock?
10 analysts have analysed EPRX.CA and the average price target is 12.36 CAD. This implies a price increase of 45.71% is expected in the next year compared to the current price of 8.48.
How do analysts rate EUPRAXIA PHARMACEUTICALS INC (EPRX.CA)?
The consensus rating for EUPRAXIA PHARMACEUTICALS INC (EPRX.CA) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed EUPRAXIA PHARMACEUTICALS INC (EPRX.CA)?
The number of analysts covering EUPRAXIA PHARMACEUTICALS INC (EPRX.CA) is 10.